Messori A - Search Results

1

Cecchi M, Caccese E, Messori A. Cecchi M, et al. Among authors: messori a. N Engl J Med. 2005 Sep 22;353(12):1297-8; author reply 1297-8. doi: 10.1056/NEJMc051943. N Engl J Med. 2005. PMID: 16177258 No abstract available.

2

Tenders for the Procurement of Medical Devices: Adapting Cost-Effectiveness Rules to the Requirements of the European Public Procurement Directive.

Messori A, Trippoli S, Caccese E, Marinai C. Messori A, et al. Ther Innov Regul Sci. 2020 Jan;54(1):226-231. doi: 10.1007/s43441-019-00049-7. Epub 2020 Jan 6. Ther Innov Regul Sci. 2020. PMID: 32008234

3

Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma. A lifetime cost-effectiveness analysis.

Messori A, Cecchi M, Becagli P, Trippoli S. Messori A, et al. Cancer. 1997 Jun 1;79(11):2264-6. doi: 10.1002/(sici)1097-0142(19970701)79:11<2264::aid-cncr29>3.0.co;2-s. Cancer. 1997. PMID: 9179077 No abstract available.

4

Value-based procurement of medical devices: Application to devices for mechanical thrombectomy in ischemic stroke.

Trippoli S, Caccese E, Marinai C, Messori A. Trippoli S, et al. Among authors: messori a. Clin Neurol Neurosurg. 2018 Mar;166:61-65. doi: 10.1016/j.clineuro.2018.01.028. Clin Neurol Neurosurg. 2018. PMID: 29408775

5

Treatments for relapsed-refractory diffuse large B-cell lymphoma: comparison of overall survival outcomes observed with four novel agents.

Messori A, Caccese E. Messori A, et al. Eur Rev Med Pharmacol Sci. 2022 Jul;26(13):4666-4670. doi: 10.26355/eurrev_202207_29190. Eur Rev Med Pharmacol Sci. 2022. PMID: 35856357 Free article.

6

Use of gabexate mesylate in Italian hospitals: a multicentre observational study.

Pelagotti F, Cecchi M, Messori A; Gabexate Mesylate Study Group. Pelagotti F, et al. Among authors: messori a. J Clin Pharm Ther. 2003 Jun;28(3):191-6. doi: 10.1046/j.1365-2710.2003.00480.x. J Clin Pharm Ther. 2003. PMID: 12795778

7

Estimating the 95% confidence interval for survival gain between an experimental anti-cancer treatment and a control.

Messori A, Caccese E, D'Avella MC. Messori A, et al. Ther Adv Med Oncol. 2017 Nov;9(11):721-723. doi: 10.1177/1758834017731084. Epub 2017 Sep 18. Ther Adv Med Oncol. 2017. PMID: 29344108 Free PMC article. No abstract available.

8

Biological meshes for abdominal hernia: Lack of evidence-based recommendations for clinical use.

Trippoli S, Caccese E, Tulli G, Ipponi P, Marinai C, Messori A. Trippoli S, et al. Among authors: messori a. Int J Surg. 2018 Apr;52:278-284. doi: 10.1016/j.ijsu.2018.02.046. Epub 2018 Mar 2. Int J Surg. 2018. PMID: 29501796 Free article. Review.

9

Piperacillin-Tazobactam: Extended Infusion Versus Continuous Infusion.

Messori A, Tulli G, Caccese E, Trippoli S, Marinai C. Messori A, et al. Crit Care Med. 2018 Jul;46(7):e725. doi: 10.1097/CCM.0000000000003115. Crit Care Med. 2018. PMID: 29912125 No abstract available.

10

The role of bortezomib, thalidomide and lenalidomide in the management of multiple myeloma: an overview of clinical and economic information.

Messori A, Maratea D, Nozzoli C, Bosi A. Messori A, et al. Pharmacoeconomics. 2011 Apr;29(4):269-85. doi: 10.2165/11585930-000000000-00000. Pharmacoeconomics. 2011. PMID: 21395348 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters